Patent · US Active

Long-acting injectable formulations and use thereof

US12350281B2 · kind B2 · utility

0Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 20, 2020
Grant dateJul 8, 2025
Priority date—
Expiry dateJun 2, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.